Evaluation of point-of-care instrument for quantification of infliximab and adalimumab​Mark Ainsworth Torben Knudsen Karina Vogn Koch Mads Nybo Morten Beck Trelle a Department of Gastroenterology, Odense University Hospital, Odense, Denmarkb Department of Gastroenterology, Grindsted, Esbjerg University Hospital, Esbjerg, Denmarkc Department of Clinical Biochemistry, Odense University Hospital, Svendborg, Denmarkd Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmarkon September 12, 2025 at 9:35 am